Natriumchloride Fresenius Kabi (Sodium Chloride)

Sodium chloride, the active ingredient in Natriumchloride Fresenius Kabi, is an electrolyte presented as an injection solution for parenteral use. It provides sodium and chloride ions to restore extracellular fluid volume and electrolyte balance in patients who need fluid replacement, electrolyte replenishment, or correction of hyponatremia, and is marketed in the European Union.

GNH USA supplies Natriumchloride Fresenius Kabi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics across the globe worldwide.

Natriumchloride Fresenius Kabi, an injectable electrolyte solution, is used in clinical situations that require restoration of fluid and electrolyte balance.

Fluid replacement: Replenishes intravascular volume in patients with dehydration, blood loss, or surgical fluid loss. Electrolyte replenishment: Restores sodium and chloride concentrations in individuals with electrolyte deficits. Hyponatremia: Corrects low serum sodium levels by providing controlled sodium supplementation.

Common Side Effects: - Injection site pain or irritation - Phlebitis or local inflammation - Mild hypernatremia if administered rapidly - Transient rash or mild hypersensitivity - Peripheral edema due to fluid shift - Elevated blood pressure in susceptible patients

Serious or Rare Side Effects: - Severe hypernatremia leading to neurological symptoms - Anaphylactic or severe allergic reaction - Cardiac arrhythmia from electrolyte disturbances - Volume overload causing pulmonary edema - Acute kidney injury in patients with compromised renal function - Central pontine myelinolysis with overly rapid correction of hyponatremia

Before administering Natriumchloride Fresenius Kabi, consider the following precautions.

Assess patient fluid status: Evaluate volume status and signs of dehydration or overload. Monitor serum electrolytes: Check sodium and chloride levels during therapy. Use aseptic technique: Prevent contamination of the injection solution. Avoid rapid infusion: Infuse over the recommended time to reduce cardiovascular stress. Renal impairment: Adjust volume in patients with reduced kidney function. Store at 2-8°C: Keep refrigerated, protect from light, do not freeze or shake.

Natriumchloride Fresenius Kabi may interact with other medications. Review the following.

Major Interactions (Avoid): - Concurrent hypertonic saline: May cause severe hypernatremia. - Loop diuretics: Can exacerbate electrolyte shifts and volume changes. - Corticosteroids: May increase sodium retention leading to volume overload.

Moderate Interactions (Monitor Closely): - ACE inhibitors: Monitor blood pressure and potassium levels. - NSAIDs: May affect renal handling of sodium and fluid balance. - Vasopressin analogues: May potentiate water retention and hyponatremia risk.